Answers are grounded in this paper and cite their sources.
This study was dedicated to evaluating the impact of the Sodium-GLucose coTransporter 2 (SGLT2) inhibitor dapagliflozin on renal and cardiometabolic parameters in patients with a combination of arterial hypertension (AH) and type 2 diabetes mellitus (T2DM). Over the course of 12 months, 77 patients with confirmed AH and T2DM received dapagliflozin at a daily dose of 10 mg as part of their combination therapy, which also included standard antihypertensive medications and statins. A comprehensive clinical and instrumental examination was conducted before and after treatment, which included anthropometric measurements (body mass index), laboratory evaluation of glycemic and lipid profiles, renal biomarkers (cystatin C, β2-microglobulin, Neutrophil Gelatinase-Associated Lipocalin (NGAL), and estimated glomerular filtration rate), and cardiac function markers such as N-Terminal pro-B-type Natriuretic Peptide (NT-proBNP). Echocardiographic assessment focused on evaluating changes in both structural and functional characteristics of the heart, with particular emphasis on left ventricular systolic and diastolic performance. After 12 months of dapagliflozin treatment, there was a statistically significant improvement in glycemic control and lipid metabolism, along with a reduction in body mass index. Furthermore, favorable changes were observed in renal function parameters, suggesting nephroprotective effects. A substantial decrease in NT-proBNP levels was also noted, reflecting reduced myocardial stress. Echocardiographic findings confirmed reverse remodeling of the left ventricle and improved cardiac performance. These results support the use of dapagliflozin as a multifactorial agent that exerts metabolic, renal, and cardiovascular benefits in patients with combined AH and T2DM, indicating its value in integrated cardiometabolic care.
No takes yet. Share an insight, caveat, or question.
Інна Дунаєва (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: